Ernexa Therapeutics Inc. Warrants (ERNAW)
ERNAW trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.0280
-6.67% on the day
Market cap
$46K
Nano cap
Revenue · 2024
$582K
+755.9% on 2023
Net income · 2024
-$44.5M
-7652.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2024.
Profile
| Field | Value |
|---|---|
| Ticker | ERNAW on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000748592 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $582K |
| Net income | -$44.5M |
| Operating income | -$15.7M |
| Net margin | -7652.7% |
| Operating margin | -2693.1% |
| Revenue growth | +755.9% |
| Cash | $1.7M |
| Total assets | $5.3M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-03-16 |
| Latest annual report | 10-K | 2026-03-13 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-09-16 |
| Latest proxy | DEFA14A | 2026-05-11 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| ERNA | Ernexa Therapeutics Inc. | $2.21 |
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| REVBW | Revelation Biosciences Inc. Warrant | $0.0051 | -33.77% | $20K |
| CDT | CDT Equity Inc. | $0.4500 | -31.82% | $506K |
| SXTC | China SXT Pharmaceuticals Inc. | $0.0774 | -24.12% | $802K |
| BDRX | Biodexa Pharmaceuticals plc American Depositary Shs | $0.3502 | -8.61% | $1.5M |
| ARTL | Artelo Biosciences Inc. | $2.98 | -4.18% | $1.6M |
| LABT | Lakewood-Amedex Biotherapeutics Inc. | $0.6939 | -5.08% | $1.6M |
| OGEN | Oragenics Inc. | $0.4469 | -0.16% | $2.0M |
| GNPX | Genprex Inc. | $2.51 | -6.69% | $2.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier